Global Markets: Asia stocks nurse losses, bonds hold huge gains
By Wayne Cole SYDNEY (Reuters) - Asian shares were heading for weekly losses on Friday as conflicting messages on the Sino-U.S. trade war only added to worries for the global economy, while talk of aggressive central bank stimulus drove bond yields to fresh lows. U.S.
By Wayne Cole
SYDNEY (Reuters) - Asian shares were heading for weekly losses on Friday as conflicting messages on the Sino-U.S. trade war only added to worries for the global economy, while talk of aggressive central bank stimulus drove bond yields to fresh lows.
U.S. President Donald Trump said on Thursday he believed China wanted to make a trade deal and that the dispute would be fairly short.
Beijing on Thursday vowed to counter the latest tariffs on $300 billion of Chinese goods but called on the United States to meet it halfway on a potential trade deal.
With no settlement in sight, investors chose discretion over valour. MSCI's broadest index of Asia-Pacific shares outside Japan <.MIAPJ0000PUS> eased 0.17%, to be down 1.4% for the week.
Japan's Nikkei <.N225> fell 0.5%, making a loss of 1.8% on the week, while commodity-exposed Australia <.AXJO> was heading for a weekly drubbing of 2.7%.
E-Mini futures for the S&P 500
The spectacular rally in bonds remained the main investor focus. Yields on 30-year paper
That meant investors were willing to lend the government money for three decades for less than the overnight rate.
Such is the gloom that surprisingly strong U.S. retail sales came and went with no impact on the bond rally.
Analysts have cautioned that the current bond market is a different beast than in the past and might not be sending a true signal on recession.
"The bond market may have got it wrong this time, but we would not dismiss the latest recession signals on grounds of distortions," said Simon MacAdam, global economist at Capital Economics.
"Rather, it is of some comfort for the world economy that unlike all previous U.S. yield curve inversions, the Fed has already begun loosening monetary policy this time."
There were plenty of other signs the cavalry were coming. European Central Banker Olli Rehn on Thursday flagged the need for a significant easing package in September.
Markets are keyed for a cut in the deposit rate of at least 10 basis points and a resumption of bond buying, sending German 10-year bund yields
"Notions that the package will include a revamped QE programme also saw a sharp rally in Italian, Spanish and Portuguese debt," said Tapas Strickland, a director of economics at National Australia Bank.
"If the ECB undertakes such substantive stimulus, it is unlikely to do so alone given the upward pressure it would put on the U.S. dollar."
Mexico overnight became the latest country to surprise with a cut in rates, the first in five years.
Canada's yield curve inverted by the most in nearly two decades, piling pressure on the Bank of Canada to act.
All the talk of ECB easing knocked the euro back to $1.1108
The dollar could make little headway on the safe-haven yen, though, and faded to 106.08 yen
The collapse in bond yields continued to make non-interest paying gold look relatively more attractive and the metal held firm at $1,524.90
Oil prices were trying to bounce after two days of sharp losses. Brent crude
(Editing by Sam Holmes)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment
SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.
CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.